Blood tests may predict when lung cancer returns after surgery
NCT ID NCT07170046
Summary
This study aims to see if tracking two specific markers in the blood (CEA and ctDNA) can help predict when lung cancer might return after surgery. Researchers will follow 100 patients who have had surgery for lung cancer and monitor their blood levels over two years. The goal is to better understand recurrence patterns so doctors can personalize follow-up care and potentially adjust treatments sooner.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.